Sector
HealthcareOpen
₹59.19Prev. Close
₹62.3Turnover(Lac.)
₹0.33Day's High
₹64Day's Low
₹59.1952 Week's High
₹106.7852 Week's Low
₹25Book Value
₹10.8Face Value
₹10Mkt Cap (₹ Cr.)
65.82P/E
75.98EPS
0.82Divi. Yield
0Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Equity Capital | 10.29 | 10.29 | 10.29 | 10.29 |
Preference Capital | 6.01 | 5.89 | 5.79 | 5.7 |
Reserves | -5.08 | -2.47 | -2.43 | -6.91 |
Net Worth | 11.22 | 13.71 | 13.65 | 9.08 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Revenue | 15.2 | 8.41 | 4.35 | 0.75 |
yoy growth (%) | 80.66 | 93.13 | 474.3 | 0 |
Raw materials | -2.63 | -1.98 | -1.3 | -0.14 |
As % of sales | 17.32 | 23.61 | 29.87 | 18.73 |
Employee costs | -4.02 | -4.94 | -3.42 | -1.61 |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Profit before tax | 1.38 | -4.21 | -5.58 | -2.72 |
Depreciation | -1.44 | -1.66 | -1.12 | -0.19 |
Tax paid | 0 | -0.02 | 0 | 0 |
Working capital | 0.85 | 0.84 | -1.33 | -3.37 |
Other operating items |
Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 80.66 | 93.13 | 474.3 | 0 |
Op profit growth | -292.22 | -52.81 | 50.34 | 979.16 |
EBIT growth | -171.01 | -33.01 | 93.64 | -3,067.65 |
Net profit growth | -132.56 | -24.03 | 104.87 | -10,028.19 |
Particulars (Rupees in Crores.) | Mar-2024 |
---|---|
Gross Sales | 13.2 |
Excise Duty | 0 |
Net Sales | 13.2 |
Other Operating Income | 0 |
Other Income | 0.42 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Max Healthcare Institute Ltd MAXHEALTH | 1,110.3 | 132.18 | 1,07,936.93 | 138.24 | 0.14 | 697.4 | 81.72 |
Apollo Hospitals Enterprise Ltd APOLLOHOSP | 6,844.9 | 81.9 | 98,419.16 | 341.6 | 0.23 | 2,054.8 | 569.62 |
Fortis Healthcare Ltd FORTIS | 662.35 | 248.07 | 50,004.65 | 39.56 | 0.15 | 366.87 | 120.23 |
Narayana Hrudayalaya Ltd NH | 1,786.95 | 85.09 | 36,518.25 | 79.22 | 0.22 | 865.04 | 95.32 |
Global Health Ltd MEDANTA | 1,188.4 | 81.34 | 31,918.92 | 99.31 | 0 | 624.4 | 113.49 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Managing Director & CEO
Pankaj Jashwant Shah
Independent Director
Mangala Radha Krishnan Prabhu
Chairman & Independent Directo
Haseeb Drabu
Executive Director
Nikunj Mange
Independent Director
Manas Mengar
Company Sec. & Compli. Officer
Krupali Shah
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Aspira Pathlab & Diagnostics Ltd
Summary
Aspira Pathlab & Diagnostics Limited (ASDL) was incorporated in July, 1973. ASDL is a leading pathology specialist, with Pan-India presence. It offer pathology and diagnostic services to individual patients, hospitals, other healthcare providers, and businesses. The Company, with a wider presence in Maharashtra India, enjoys a loyal customer base, that reflects on its strength as a brand, providing superior diagnostic testing and services.Presently, Company is engaged into the business of running, owning, managing and administering Diagnostics Centers. Its principal activities consist of pathology investigation services, radiology investigation services and other related healthcare services at Diagnostic Centres in Mumbai.During the year, the Company commenced its business activities of diagnostic center & pathology from November 2016 onwards by acquiring running business activities of Ankur Pathology Laboratory. Aspira is focused on establishing itself as a strong regional player before scaling up its operations. Although, it follow an asset light model, other costs are significantly high. Most of these cost is front ended and the payback period is high. It is therefore working on building the right systems and optimize the cost. It is adopting new technologies that improve customer experience. Some of these are use of Chatbot, improving website, implementing patient engagement platform, Customer Service, etc. Also concentrating more on HLM, trying to expand area by targetin
Read More
The Aspira Pathlab & Diagnostics Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is ₹63.95 today.
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Aspira Pathlab & Diagnostics Ltd is ₹65.82 Cr. as of 09 May ‘25
The PE and PB ratios of Aspira Pathlab & Diagnostics Ltd is 75.98 and 5.77 as of 09 May ‘25
The 52-week high/low is the highest and lowest price at which a Aspira Pathlab & Diagnostics Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Aspira Pathlab & Diagnostics Ltd is ₹25 and ₹106.78 as of 09 May ‘25
Aspira Pathlab & Diagnostics Ltd's CAGR for 5 Years at 11.29%, 3 Years at 5.54%, 1 Year at 94.08%, 6 Month at 4.15%, 3 Month at -7.43% and 1 Month at -10.24%.
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.